18th Jul 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
16th Jul 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
15th Jul 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
12th Jul 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
3rd Jul 2024 7:00 am |
RNS |
GSK and CureVac collaboration restructured |
1st Jul 2024 3:00 pm |
RNS |
Total Voting Rights |
28th Jun 2024 5:37 pm |
RNS |
Statement: Zantac (ranitidine) litigation |
24th Jun 2024 7:05 am |
RNS |
Omjjara approved in Japan for myelofibrosis |
24th Jun 2024 7:00 am |
RNS |
EMA validates Jemperli marketing authorisation |
21st Jun 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
12th Jun 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th Jun 2024 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
10th Jun 2024 6:27 pm |
RNS |
Statement: Zantac (ranitidine) litigation |
10th Jun 2024 7:00 am |
RNS |
FDA approves Arexvy for adults 50-59 at risk |
3rd Jun 2024 3:00 pm |
RNS |
Total Voting Rights |
3rd Jun 2024 1:03 pm |
RNS |
Unprecedented results in Jemperli trial continue |
3rd Jun 2024 7:05 am |
RNS |
ASCO positive Blenrep DREAMM-8 trial results |
3rd Jun 2024 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
24th May 2024 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
21st May 2024 7:00 am |
RNS |
Positive phase III asthma results for depemokimab |
20th May 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th May 2024 7:00 am |
RNS |
GSK completes sale of shares in Haleon plc |
16th May 2024 4:42 pm |
RNS |
GSK announces intention to sell shares in Haleon |
14th May 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
13th May 2024 3:00 pm |
RNS |
Block listing Interim Review |
8th May 2024 6:21 pm |
RNS |
Result of AGM |
8th May 2024 4:57 pm |
RNS |
Board Committee Change |
3rd May 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
1st May 2024 3:00 pm |
RNS |
Total Voting Rights |
1st May 2024 7:00 am |
RNS |
1st Quarter Results |
24th Apr 2024 7:00 am |
RNS |
US FDA accepts new indication filing for Jemperli |
19th Apr 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th Apr 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
17th Apr 2024 7:05 am |
RNS |
GSK announces additional EAGLE-1 results |
17th Apr 2024 7:00 am |
RNS |
Results from long-term data relating to Shingrix |
16th Apr 2024 2:11 pm |
RNS |
Amendment - Director/PDMR Shareholding |
16th Apr 2024 7:00 am |
RNS |
FDA accepts GSK meningitis vaccine candidate file |
15th Apr 2024 3:30 pm |
RNS |
Director/PDMR Shareholding |
4th Apr 2024 12:05 pm |
RNS |
Replacement - Total Voting Rights |
2nd Apr 2024 3:00 pm |
RNS |
Total Voting Rights |